Department of Drug Administration-DDA

Department of Drug Administration-DDA
Sharing is Caring !!

Department of Drug Administration-DDA

Government of Nepal established Department of Drug Administration (DDA) in 1979 A.D (2036/07/01 B.S.) established under Ministry of forest & soil conservation and went under Ministry of Health and population after Poush, 2041 B.S. DDA is one of the three departments under Ministry of Health & Population.

Nepal has promulgated the Drug Act 1978, to prohibit the misuse or abuse of medicines and allied pharmaceutical products as well as false or misleading information relating to efficacy and use of drugs and to regulate and control the production, marketing, distribution, export, import, storage and utilization of those drugs which are not safe for the public use, efficacious and of standard quality. To implement & fulfill the aim and objectives of Drug Act 1978 and various regulations are made under it.

In accordance with the objectives of the National Health Policy, 1991, to improve & manage by establishing co-ordination among governmental, non-governmental & private organizations involved in activities related to medicine production, import, export, storage, supply, sales, distribution, qualitya ssessment, regulatory control, rational use and information flow, the National Drug Policy, 1995 has been implemented. Achieving the aim & objectives of National drug policy is another important area for DDA.

Under the Drug Act 1978, the following rules/regulations & codes have been implemented as supporting tools for the active enforcement of

  • Drugs Act, 1978.
  • Drug advisory committee & consultative council regulation, 2037
  • Drug registration regulation, 2038
  • Inquiry & inspection regulation, 2040
  • Drug standard regulation, 2043
  • Drug donation guidelines have been implemented for the quality assurance of donated drugs
  • Drug sales & distribution codes, 2071
  • Good practice codes for drug production, 2072
  • Medicine registration guidance, 2073

Mission & Vision 

In accordance with the objectives of the National Health Policy 1991, to improve and manage by establishing co-ordination among governmental, non-governmental and private organizations involved in the activities related to drug production, import, export, storage, supply, sales, distribution, quality assessment, regulatory control, rational use and information flow, the National Drug Policy 1995 has been implemented. Achieving the aim and objectives of National drug Policy is another important area for DDA.

Under the Drug Act 1978, the following rules and regulation and codes have been implemented as supporting tools for the active enforcement of Drug Act 1978. Regulation on Constitution of Drug Consultative Council and Drug Advisory Committee, 2037 Drug Registration Regulation, 2038 Interrogation and Inspection Regulation, 2040 Codes on Drug Manufacturing, 2041 Drug Standard Regulation, 2043 Drug Donation guidelines have been implemented for the quality assurance of donated drugs.

Role of DDA 

The role of DDA is to regulate all functions relating drugs like misuse and abuse of drugs and its raw materials, to stop false and misleading advertisement and make available safe, efficacious and quality drugs to the general public by controlling the production, marketing, distribution, sale, export, import, storage and use of drugs. The overall activities are described in the table below:

Activities Scope/Key functions
1 Ensuring safety, quality and efficacy of medicines · Evaluation, Registration and licensing of medicines and health technology products,

· Issuance of permit to conduct clinical trial, licenses to open pharmacy and recommendation letter to establish manufacturing unit,

· Post marketing surveillance on medicines and health technology products,

· Inspection and monitoring of facilities engaged in manufacture, sales, store and distribution of medicines and health technology products,

· Testing of medicines and HTP before and after registration

2 Promotion of Rational Use of Medicines and health technology products · Development and revision of national essential medicines list,

· Development and revision of antibiotic prescription protocol,

· Information dissemination to consumer on rational use of medicines

3 Ensuring access to medicines and health care technology products · Formulate medicine policies to ensure access to medicines

· Price regulation and price transparency

· To issue permit for products in shortage (including orphan drugs)

4 Enforce provisions of drug law for regulatory compliances · Conduct medicine law awareness activities

· Develop standards and guidelines on medicine registration, pharmacy operation (including hospital pharmacy)

· Train drug inspector to effectively enforce drug law

5 Institutional development including HR · To review organizational status and develop institutional development plan

· Develop training material for regulatory and analytical staff at all level

· Conduct capacity development activities like building/construction, renovation and training of HR

· Develop capacity strengthening plan of professional in public as well as private sector engaged in medicines and health technology product manufacture, sales, storage and distribution.

· Develop transparent, responsive service delivery system (including online registration, webpage and communication)


  • Selection of essential medicine to promote rational use of medicines.
  • Establishment of provinces offices for effective decentralization.
  • Strengthening of National Medicines Laboratory (NML) as an Independent National Medicine Control Laboratory.
  • Medicine registration based on scientific facts and evidence of safety, efficacy and quality of medicine.
  • Promotion of rational use of medicines.
  • Development of an efficient medicine information system to disseminate the relevant information.
  • Encouragement to promote and establish pharmaceutical industries to achieve self-reliance in the production of essential medicines.
  • Effective inspection to ensure the quality of marketed medicines.
  • Prevent misuse of antibiotic to combat antimicrobial resistance.
  • Strengthen national industry to comply with WHO-Good Manufacturing Practices (GMP)

Division of DDA

Registration Division
Import and Export Section:

  • To  register  the  foreign  medicine  manufacturing  company  and  products  in  a  scientific  manner  for import.
  •  To issue the recommendation letter for import/export of medicines
  •  To renew the recommendation letter for import-export.

Industry Section:

  • To  issue  recommendation  letter  for  the  establishment  of  pharmaceutical  industry  and  issue Product Manufacturing License and renew them.
  • Check and approve the pharmaceutical manufacturing plant layout.
  •  Evaluate the new products and issue marketing permission for the sale & distribution.
  • Issue letter of recommendation for the import of raw materials and renew them.

Pharmacy Registration Section:

  • To register and issue registration certificates for retail / wholesale pharmacy outlet and renew them.
  • Issue and renew certificates for persons authorized to sale medicines (Vyabashahi).
  •  Update the record of pharmacies.

Management Division

Training and Drug Information Section:

  • Conduct the refresher training to medicine sellers.
  • Disseminate information about medicines particularly adverse effects, contraindication, drug Interaction and storage condition and other necessary information regarding medicines.
  •  Publish Drug Bulletin of Nepal (DBN) and distribute to health institutions, industries, medical doctors, health personnel’s, pharmacists and others concerned person and institution.
  • Recommend for import of narcotic, psychotropic, precursors substances and liaise with  International Narcotic Control Board (INCB).
  • Conduct activities related to Pharmacovigillance and Adverse Drug Monitoring Reporting.

Planning section

  • Prepare yearly planning for activities conduct by DDA and regional office.
  • Coordinate with Ministry, other department and other government and non government organization for conducting activities and submit the report to MOH.
  • Collect, prepare and forward monthly, quarterly and yearly report.

Administration section

  • Management of human resources (recruitment, posting, promotion, transfer etc)
  • Perform Procurement related activities  Monitoring and evaluation of regional offices activities.

Inspection Division :

  1. Inspect drug industries, wholesale and retail pharmacies regularly.
  2.  Take legal and administrative action on cases of non-compliance as per the provision of Drug Act and its Regulations.
  3. Regulate sales and distribution of psychotropic and narcotic drugs.
  4. Co-ordinate Good Manufacturing Practice Audit within and outside the country.
  5. Industry inspection section
  • Inspection of pharmaceutical industry as per yearly plan.
  • Take action for noncompliance related to Drug Act 2035.

Law section

  • Prepare necessary medicine related document for registering the case on court against pharmacy and industry or order issues regulated by DDA
  • Give legal suggestion to department.

Import/export section

  • Inspection for the effective implementation of Drug Act 2035 and other regulations under Drug Act.

Audit section :WHO GMP certification and Recertification related activities.

Regional Offices 

  • Biratnagar
  • Birgunj
  • Nepalgunj


Bijulibazar, New Baneshwor, Kathmandu, Nepal
Tel: (977) 1 4780 227, 4780432
Fax: (977) 1 4780572

Sharing is Caring !!

(1) Comment

  • Bhuwan kushwaha March 16, 2020 @ 2:41 am

    I hv deposited the money in bank but I couldn’t fill up the form and it’s showing application form closed since 3pm of 11/11/ is their any other process to fill up the form and if not available how could I get my money refund.

Leave a Reply

Your email address will not be published. Required fields are marked *

Nepal Pharmacy Council-NPC Nepal Pharmacy Council is established in 2058…
Cresta Posts Box by CP